HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, X. Articles by Poole, C. Search for Related Content PubMed PubMed Citation Articles by Huang, X. Articles by Poole, C. Related Collections Parkinson's disease/Parkinsonism Screening in epidemiology All Genetics Association studies in genetics

APOE-2 allele associated with higher prevalence of sporadic Parkinson disease

From the Department of Neurology, University of North Carolina School of Medicine, and the Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC.

Address correspondence and reprint requests to Dr. Xuemei Huang, Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7025; e-mail: xuemei{at}med.unc.edu

Background: The link of the apolipoprotein (APOE) -4 allele to Alzheimer disease (AD) has led to studies investigating the role of apoE polymorphisms in Parkinson disease (PD). The authors hypothesized that any association between PD and APOE alleles and genotypes would be too small to be detected or precisely estimated by an individual case-controlled study.

Method: The hypothesis was tested by systematic review and meta-analysis of results from case-control studies that provided clear clinical or pathologic criteria for PD and that reported APOE genotype frequencies. Published reports were obtained from MEDLINE, Biosis Previews, and ISI Web of Science searches, supplemented by citation analysis from retrieved articles. The authors estimated and compared prevalence odds ratios (OR) for PD in relation to each allele and genotype.

Results: Twenty-two eligible studies were identified. There was no evidence of heterogeneity (p > 0.4) or publication bias (p > 0.2) for any allele or genotype. The estimated summary OR for one or more copies of each APOE allele was 1.20 for APOE-2 (95% CI, 1.02 to 1.42), 0.83 for APOE-3 (95% CI, 0.63 to 1.09), and 0.99 for APOE-4 (95% CI, 0.87 to 1.14).

Conclusions: Unlike Alzheimer disease, for which the APOE-4 allele increases the prevalence and the APOE-2 allele is protective, the authors’ analysis shows the APOE-2 allele, but not the APOE-4 allele, to be positively associated with sporadic Parkinson disease.

Received November 10, 2003. Accepted in final form February 18, 2004.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the June 22 issue to find the title link for this article.

This article has been cited by other articles:

				L. M. L. de Lau, P. J. Koudstaal, A. Hofman, and M. M. B. Breteler Serum Cholesterol Levels and the Risk of Parkinson's Disease Am. J. Epidemiol., November 15, 2006; 164(10): 998 - 1002. [Abstract] [Full Text] [PDF]

				L. M. L. de Lau, C. M. A. Schipper, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler Prognosis of Parkinson Disease: Risk of Dementia and Mortality: The Rotterdam Study Arch Neurol, August 1, 2005; 62(8): 1265 - 1269. [Abstract] [Full Text] [PDF]

				Papers of Note Sci. Aging Knowl. Environ., June 30, 2004; 2004(26): nw25 - nw25. [Full Text]